{"id":758,"date":"2022-11-29T00:00:00","date_gmt":"2022-11-28T23:00:00","guid":{"rendered":"https:\/\/liuinvest.se\/2022\/11\/29\/co-investment-with-uu-invest-and-slu-holding-in-new-cancer-therapy\/"},"modified":"2026-10-13T10:16:55","modified_gmt":"2026-10-13T08:16:55","slug":"co-investment-with-uu-invest-and-slu-holding-in-new-cancer-therapy","status":"publish","type":"post","link":"https:\/\/liuinvest.se\/en\/2022\/11\/29\/co-investment-with-uu-invest-and-slu-holding-in-new-cancer-therapy\/","title":{"rendered":"Co-investment with UU Invest and SLU Holding in New Cancer Therapy"},"content":{"rendered":"<p>MyCural Therapeutics develops drug candidates for cancer treatment. The objective is to develop new treatments for patients with aggressive, resistant, metastatic high-risk tumors. <\/p>\n<p>The investment is being made in conjunction with UU Invest.<\/p>\n<p>&#8220;Being able to collaborate with our colleagues in Uppsala, who have extensive experience in life science, is a great advantage for us,&#8221; says Jonas Nilsson, Investment Manager, LiU Invest.<\/p>\n<p>In connection with this investment, private investors are also participating, and the company is raising approximately SEK 3 million in total.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MyCural Therapeutics develops drug candidates for cancer treatment. The objective is to develop new treatments for patients with aggressive, resistant, metastatic high-risk tumors. The investment is being made in conjunction with UU Invest. &#8220;Being able to collaborate with our colleagues in Uppsala, who have extensive experience in life science, is a great advantage for us,&#8221; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[25,28],"tags":[],"class_list":["post-758","post","type-post","status-publish","format-standard","hentry","category-investment","category-new-investment"],"acf":[],"_links":{"self":[{"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/posts\/758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/comments?post=758"}],"version-history":[{"count":0,"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/posts\/758\/revisions"}],"wp:attachment":[{"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/media?parent=758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/categories?post=758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/liuinvest.se\/en\/wp-json\/wp\/v2\/tags?post=758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}